Get the Stockscreener App
0.31
1.64%
0.005
After Hours:
.30
-0.01
-3.23%
Cara Therapeutics Inc Stock (CARA) Forecast
The Cara Therapeutics Inc (CARA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.3753, representing a +1,634% increase from the current price of $0.31. The highest analyst price target is $10.38, and the lowest is $0.3668.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CARA Price Target
Average 5.1978
(+1,577% Upside)
Is Cara Therapeutics Inc (CARA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.09 | Neutral |
| STOCH(9,6) | 32.88 | Neutral |
| STOCHRSI(14) | 27.15 | Neutral |
| MACD(12,26) | 0.00711 | Sell |
| ADX(14) | 25.50 | Buy |
| William %R | -64.64 | Neutral |
| CCI(14) | -34.53 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3193
Sell
|
0.3104
Sell
|
| MA20 |
0.3067
Buy
|
0.3055
Buy
|
| MA50 |
0.2873
Buy
|
0.3043
Buy
|
| MA100 |
0.3121
Sell
|
0.3578
Sell
|
| MA200 |
0.5103
Sell
|
0.5966
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, CARA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CARA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 53.09 indicates that CARA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 32.88 indicates that CARA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.15 indicates that CARA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.5 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -34.53 indicates that CARA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CARA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cara Therapeutics Inc financial reports and earnings history, Cara Therapeutics Inc (CARA) stock could reach $17.00 by 2030, $8.9659 by 2040 and $31.94 by 2050. See the projected annual prices until 2050 of the Cara Therapeutics Inc stock below:
- Cara Therapeutics Inc (CARA) is expected to reach an average price of $3.8002 in 2035, with a high prediction of $3.9519 and a low estimate of $3.8806. This indicates an $1,126% rise from the last recorded price of $0.31.
- Cara Therapeutics Inc (CARA) stock is projected to chart a bullish course in 2040, with an average price target of $9.0296, representing an $2,813% surge from its current level. The forecast ranges from a conservative $9.1991 to a sky-high $8.9659.
- Our analysts predict Cara Therapeutics Inc (CARA) to jump 4,999% by 2045, soaring from $16.20 to an average price of $15.81, potentially reaching $16.05. While $16.20 is the low estimate, the potential upside is significant.
- Cara Therapeutics Inc (CARA) stock is expected to climb by 2050, reaching an average of $29.39, a $9,379% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.94 and $30.47, respectively, highlighting the market's uncertainty.
Cara Therapeutics Inc Stock (CARA) Year by Year Forecast
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2024
Our forecast for CARA stock price in 2024 now indicates an average price target of $5.296 with a high forecast of $10.38 and a low forecast of $0.2083. The average prediction reflects an increase of +1,608% from the last recorded price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.5632 | $0.3668 | $10.38 | +81.67% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2025
Cara Therapeutics Inc Stock (CARA) is expected to reach an average price of $2.6473 in 2025, with a high prediction of $5.2828 and a low estimate of $0.0118. This indicates an +753.95% rise from the last recorded price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.9249 | $0.0474 | $1.4426 | +198.36% |
| February, 2025 | $0.3976 | $0.0118 | $2.5682 | +28.27% |
| March, 2025 | $0.7848 | $0.087 | $2.3358 | +153.18% |
| April, 2025 | $2.2279 | $0.6655 | $3.8867 | +618.69% |
| May, 2025 | $0.0454 | $0.4004 | $2.0286 | -85.35% |
| June, 2025 | $0.3571 | $0.041 | $1.764 | +15.20% |
| July, 2025 | $2.244 | $0.314 | $2.3546 | +623.88% |
| August, 2025 | $3.4815 | $2.0034 | $3.8015 | +1,023% |
| September, 2025 | $3.0391 | $2.2397 | $4.7109 | +880.35% |
| October, 2025 | $1.626 | $1.14 | $5.2828 | +424.51% |
| November, 2025 | $0.6515 | $0.5259 | $2.3854 | +110.16% |
| December, 2025 | $0.1804 | $0.0123 | $2.091 | -41.80% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2026
The predicted value for Cara Therapeutics Inc (CARA) in 2026 is set at an average of $9.2025. Estimates vary from a peak of $18.05 to a trough of $0.3527, indicating an +2,869% surge from the present price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.1079 | $0.3527 | $3.5186 | +579.98% |
| February, 2026 | $2.5155 | $1.7373 | $2.7802 | +711.44% |
| March, 2026 | $6.193 | $2.0748 | $6.4102 | +1,898% |
| April, 2026 | $7.9599 | $5.8718 | $10.47 | +2,468% |
| May, 2026 | $7.7974 | $4.8087 | $8.3493 | +2,415% |
| June, 2026 | $17.59 | $7.1668 | $18.05 | +5,576% |
| July, 2026 | $1.9019 | $0.5019 | $17.95 | +513.50% |
| August, 2026 | $2.8994 | $1.7212 | $3.1194 | +835.29% |
| September, 2026 | $3.1463 | $2.5459 | $4.0675 | +914.93% |
| October, 2026 | $2.2638 | $0.6938 | $3.3057 | +630.26% |
| November, 2026 | $5.4913 | $1.6332 | $7.902 | +1,671% |
| December, 2026 | $5.4383 | $4.1895 | $6.2583 | +1,654% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cara Therapeutics Inc (CARA) is $4.6811, with a high forecast of $9.3539 and a low forecast of $0.00834. This indicates an +1,410% increase from the last price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9358 | $2.7308 | $5.5426 | +847.03% |
| February, 2027 | $4.6633 | $2.9852 | $9.3539 | +1,404% |
| March, 2027 | $3.2302 | $2.4002 | $4.9927 | +942.00% |
| April, 2027 | $2.9677 | $2.4584 | $3.9284 | +857.34% |
| May, 2027 | $1.9153 | $1.6553 | $3.6412 | +517.83% |
| June, 2027 | $2.2522 | $1.0634 | $3.4222 | +626.51% |
| July, 2027 | $3.9397 | $1.9916 | $4.4897 | +1,171% |
| August, 2027 | $4.1472 | $3.9591 | $5.9922 | +1,238% |
| September, 2027 | $0.5641 | $0.0941 | $4.2066 | +81.98% |
| October, 2027 | $0.6017 | $0.00834 | $1.6523 | +94.08% |
| November, 2027 | $2.5992 | $0.786 | $2.7392 | +738.45% |
| December, 2027 | $4.6061 | $1.1667 | $6.0761 | +1,386% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2028
In 2028, Cara Therapeutics Inc (CARA) is projected to reach an average price of $3.6656, with a high projection of $7.3082 and a low estimate of $0.023. This indicates an +1,082% rise from the last price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.9736 | $3.5742 | $5.0055 | +1,182% |
| February, 2028 | $2.9311 | $1.8611 | $4.6729 | +845.53% |
| March, 2028 | $3.2681 | $2.3805 | $4.7393 | +954.21% |
| April, 2028 | $5.2956 | $2.5468 | $5.6562 | +1,608% |
| May, 2028 | $4.7025 | $4.6025 | $7.0837 | +1,417% |
| June, 2028 | $6.44 | $3.9819 | $6.49 | +1,977% |
| July, 2028 | $5.7575 | $5.7175 | $7.3082 | +1,757% |
| August, 2028 | $1.2344 | $1.1544 | $6.1369 | +298.21% |
| September, 2028 | $0.032 | $0.023 | $1.4238 | -89.69% |
| October, 2028 | $0.0395 | $0.3255 | $0.1399 | -87.26% |
| November, 2028 | $0.9636 | $0.381 | $0.7836 | +210.84% |
| December, 2028 | $0.9861 | $0.8148 | $0.6339 | +218.09% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2029
The 2029 price forecast for Cara Therapeutics Inc Stock (CARA) is $8.1215 on average, with a high prediction of $16.18 and a low estimate of $0.0651. This represents an +2,520% increase from the previous price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1892 | $0.2592 | $0.7673 | -38.98% |
| February, 2029 | $0.5016 | $0.441 | $0.281 | +61.82% |
| March, 2029 | $0.7041 | $0.6622 | $0.6435 | +127.13% |
| April, 2029 | $1.3866 | $1.3247 | $1.191 | +347.28% |
| May, 2029 | $1.4597 | $1.4291 | $1.3478 | +370.86% |
| June, 2029 | $1.2121 | $1.342 | $1.3115 | +291.01% |
| July, 2029 | $1.2916 | $1.0534 | $1.2346 | +316.65% |
| August, 2029 | $1.1721 | $1.1877 | $1.2565 | +278.10% |
| September, 2029 | $0.5931 | $0.8902 | $1.0883 | +91.32% |
| October, 2029 | $0.32 | $0.4027 | $0.4308 | +3.22% |
| November, 2029 | $0.3048 | $0.2745 | $0.1839 | -1.69% |
| December, 2029 | $17.43 | $0.0651 | $16.18 | +5,522% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2030
Cara Therapeutics Inc Stock (CARA) is expected to reach an average price of $13.86 in 2030, with a high forecast of $19.16 and a low forecast of $8.5624. This signifies an +4,372% surge from the last price of $0.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.18 | $16.01 | $17.00 | +5,119% |
| February, 2030 | $11.06 | $13.82 | $14.95 | +3,467% |
| March, 2030 | $12.04 | $10.92 | $10.53 | +3,784% |
| April, 2030 | $10.93 | $11.55 | $10.84 | +3,425% |
| May, 2030 | $15.48 | $11.70 | $15.13 | +4,894% |
| June, 2030 | $13.23 | $14.15 | $14.09 | +4,169% |
| July, 2030 | $8.5911 | $11.78 | $12.47 | +2,671% |
| August, 2030 | $15.44 | $8.5624 | $15.03 | +4,879% |
| September, 2030 | $16.05 | $15.96 | $15.79 | +5,078% |
| October, 2030 | $13.50 | $14.00 | $15.02 | +4,254% |
| November, 2030 | $19.16 | $14.17 | $16.30 | +6,081% |
| December, 2030 | $17.45 | $18.11 | $19.16 | +5,528% |
0.93%
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):